Protein & Cell >

2023 , Vol. 14 >Issue 4: 294 - 298

DOI: https://doi.org/10.1093/procel/pwac024

LETTER

The host microbiota is associated with the occurrence and development of esophageal squamous cell carcinoma

  • Jing Zuo , 1 ,
  • Yanjun Liu 1 ,
  • Wenjing Lv 1 ,
  • Yudong Wang 1 ,
  • Zhisong Fan 1 ,
  • Long Wang 1 ,
  • Li Feng 1 ,
  • Xue Zhang 1 ,
  • Jing Han 1 ,
  • Zhiyu Ni , 2,3
Expand
  • 1. Department of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
  • 2. The Affiliated Hospital of Hebei University, Baoding 071000, China
  • 3. School of Basic Medical Science, Hebei University, Baoding 071000, China
wdh970916@163.com
nizhiyu@hbu.edu.cn

Accepted date: 25 Feb 2022

Copyright

2022 ©The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.
Fold

Cite this article

Jing Zuo , Yanjun Liu , Wenjing Lv , Yudong Wang , Zhisong Fan , Long Wang , Li Feng , Xue Zhang , Jing Han , Zhiyu Ni . The host microbiota is associated with the occurrence and development of esophageal squamous cell carcinoma[J]. Protein & Cell, 2023 , 14(4) : 294 -298 . DOI: 10.1093/procel/pwac024

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011;140:1720–1728.

DOI

2
Chen X, Winckler B, Lu M, et al. Oral microbiota and risk for esophageal squamous cell carcinoma in a high-risk area of China. PLoS One 2015;10:e0143603.

DOI

3
Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308:1635–1638.

DOI

4
He Y, Wu W, Wu S, et al. Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome 2018;6:172.

DOI

5
Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 2017;5:14.

DOI

6
Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut 2016;65:330–339.

DOI

7
Marchesi JR, Dutilh BE, Hall N, et al. Towards the human colorectal cancer microbiome. PLoS One 2011;6:e20447.

DOI

8
May M, Abrams JA. Emerging insights into the esophageal microbiome. Curr Treat Options Gastroenterol 2018;16:72–85.

DOI

9
Poore GD, Kopylova E, Zhu Q, et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 2020;579:567–574.

DOI

10
Shao D, Vogtmann E, Liu A, et al. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. Cancer 2019;125:3993–4002.

DOI

11
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin 2021;71:209–249.

DOI

12
Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013;342:971–976.

DOI

13
Wang J, Kurilshikov A, Radjabzadeh D, et al. Meta-analysis of human genome-microbiome association studies: the MiBioGen consortium initiative. Microbiome 2018;6:101.

DOI

14
Yamamura K, Baba Y, Nakagawa S, et al. Human Microbiome fusobacterium nucleatum in esophageal cancer tissue is associated with prognosis. Clin Cancer Res 2016;22:5574–5581.

DOI

15
Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222–227.

DOI

Options
Outlines

/

〈 〉